PLAU, plasminogen activator, urokinase, 5328

N. diseases: 439; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction 		0.510 Therapeutic disease CTD_human [Use of urokinase in acute myocardial infarction]. 3068399 1988
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction 		0.510 Biomarker disease CTD_human [Use of urokinase in acute myocardial infarction]. 3068399 1988
CUI: C0040053
Disease: Thrombosis
Thrombosis 		0.500 Therapeutic phenotype CTD_human [Treatment of massive arterial thrombosis caused by thrombocytopenia induced by heparin with local thrombolysis]. 2106299 1990
CUI: C0087086
Disease: Thrombus
Thrombus 		0.300 Therapeutic phenotype CTD_human [Treatment of massive arterial thrombosis caused by thrombocytopenia induced by heparin with local thrombolysis]. 2106299 1990
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction 		0.510 Therapeutic disease CTD_human [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase]. 1908371 1991
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction 		0.510 Biomarker disease CTD_human [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase]. 1908371 1991
CUI: C0040053
Disease: Thrombosis
Thrombosis 		0.500 Therapeutic phenotype CTD_human [Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats]. 12830724 2003
CUI: C0087086
Disease: Thrombus
Thrombus 		0.300 Therapeutic phenotype CTD_human [Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats]. 12830724 2003
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction 		0.310 Therapeutic disease CTD_human [Endovascular embolization of cerebral arteriovenous malformation]. 12133459 2002
CUI: C0751010
Disease: Cerebral Infarction, Left Hemisphere
Cerebral Infarction, Left Hemisphere 		0.300 Therapeutic phenotype CTD_human [Endovascular embolization of cerebral arteriovenous malformation]. 12133459 2002
CUI: C0751011
Disease: Cerebral Infarction, Right Hemisphere
Cerebral Infarction, Right Hemisphere 		0.300 Therapeutic phenotype CTD_human [Endovascular embolization of cerebral arteriovenous malformation]. 12133459 2002
CUI: C0751012
Disease: Anterior Choroidal Artery Infarction
Anterior Choroidal Artery Infarction 		0.300 Therapeutic phenotype CTD_human [Endovascular embolization of cerebral arteriovenous malformation]. 12133459 2002
CUI: C0751014
Disease: Subcortical Infarction
Subcortical Infarction 		0.300 Therapeutic disease CTD_human [Endovascular embolization of cerebral arteriovenous malformation]. 12133459 2002
CUI: C0887799
Disease: Posterior Choroidal Artery Infarction
Posterior Choroidal Artery Infarction 		0.300 Therapeutic phenotype CTD_human [Endovascular embolization of cerebral arteriovenous malformation]. 12133459 2002
CUI: C0023891
Disease: Liver Cirrhosis, Alcoholic
Liver Cirrhosis, Alcoholic 		0.200 Biomarker disease RGD [Effects of Qinggan Huoxue Recipe and its separated recipes on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 fibrinolytic system in rats with alcoholic liver fibrosis]. 19615318 2009
CUI: C0034069
Disease: Pulmonary Fibrosis
Pulmonary Fibrosis 		0.240 Therapeutic disease RGD [Effects of aerosolized earthworm fibrinolytic enzyme on bleomycin induced pulmonary fibrosis in rats]. 23327706 2012
CUI: C0007787
Disease: Transient Ischemic Attack
Transient Ischemic Attack 		0.200 Biomarker disease RGD [Effects of acupoint-embedment of medicated-thread and acupoint-injection on expression of cortical urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in rats with cerebral ischemia-reperfusion injury]. 21375013 2010
CUI: C0035126
Disease: Reperfusion Injury
Reperfusion Injury 		0.500 Therapeutic disease CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C0238281
Disease: Middle Cerebral Artery Syndrome
Middle Cerebral Artery Syndrome 		0.300 Therapeutic phenotype CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C0740376
Disease: Middle Cerebral Artery Thrombosis
Middle Cerebral Artery Thrombosis 		0.300 Therapeutic disease CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C0740391
Disease: Middle Cerebral Artery Occlusion
Middle Cerebral Artery Occlusion 		0.300 Therapeutic disease CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C0740392
Disease: Infarction, Middle Cerebral Artery
Infarction, Middle Cerebral Artery 		0.300 Therapeutic disease CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C0751845
Disease: Middle Cerebral Artery Embolus
Middle Cerebral Artery Embolus 		0.300 Therapeutic phenotype CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C0751846
Disease: Left Middle Cerebral Artery Infarction
Left Middle Cerebral Artery Infarction 		0.300 Therapeutic phenotype CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C0751847
Disease: Embolic Infarction, Middle Cerebral Artery
Embolic Infarction, Middle Cerebral Artery 		0.300 Therapeutic phenotype CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004